Literature DB >> 239102

Haemorrhagic and perivenous encephalitis: a clinical-pathological review of 38 cases.

M N Hart, K M Earle.   

Abstract

Clinical and pathological data from eight cases of acute haemorrhagic leucoencephalitis (AHL) confirm the previously documented devastating features of this disease. Data from 30 cases of perivenous encephalitis (PVE) associated with viral diseases reveal pathological changes ranging from lymphocytic cuffing of vessels to severe vasculitis similar to the vasculitis of AHL. Relatively few cases show demyelination as a prominent feature. The pathological changes are unrelated to the type of underlying disease with the exception that the pathology of 'post-rubella' encephalitis tends to be mild. Two cases of rubeola and two of mumps showed viral nodules in the cortex, raising the possibility of direct viral invasion of tissue. Allowing for species differences, these changes are analogous to the pathological features of experimental allergic encephalitis (EAE); with the various pathological changes of PVE paralleling the features of ordinary EAE, while the changes of AHL and the severe cases of PVE strongly resemble hyperacute EAE.

Entities:  

Mesh:

Year:  1975        PMID: 239102      PMCID: PMC492033          DOI: 10.1136/jnnp.38.6.585

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  13 in total

1.  ALLERGIC ENCEPHALOMYELITIS: A HYPERACUTE FORM.

Authors:  S LEVINE; E J WENK
Journal:  Science       Date:  1964-12-25       Impact factor: 47.728

2.  The nosological unity of acute haemorrhagic leucoencephalitis and acute disseminated encephalomyelitis.

Authors:  D S RUSSELL
Journal:  Brain       Date:  1955-09       Impact factor: 13.501

3.  Neuropathologic variations in experimental allergic encephalomyelitis; hemorrhagic encephalomyelitis, perivenous encephalomyelitis, diffuse encephalomyelitis, patchy gliosis.

Authors:  A FERRARO; L ROIZIN
Journal:  J Neuropathol Exp Neurol       Date:  1954-01       Impact factor: 3.685

4.  Acute necrotizing hemorrhagic encephalopathy.

Authors:  P O Behan; M J Moore; J B Lamarche
Journal:  Postgrad Med       Date:  1973-10       Impact factor: 3.840

5.  The in vitro demyelinating activity of sera from guinea pigs sensitized with whole CNS and with purified encephalitogen.

Authors:  F J Seil; G A Falk; M W Kies; E C Alvord
Journal:  Exp Neurol       Date:  1968-12       Impact factor: 5.330

6.  Central nervous system mumps. A review of 64 cases.

Authors:  L P Levitt; T A Rich; S W Kinde; A L Lewis; E H Gates; J O Bond
Journal:  Neurology       Date:  1970-08       Impact factor: 9.910

7.  Encephalitis and childhood illnesses.

Authors:  L D Polk
Journal:  Clin Pediatr (Phila)       Date:  1971-04       Impact factor: 1.168

8.  A new look at mumps encephalitis: inclusion bodies and cytopathic effects.

Authors:  G Margolis; L Kilham; J R Baringer
Journal:  J Neuropathol Exp Neurol       Date:  1974-01       Impact factor: 3.685

9.  Mechanism of demyelination in JHM virus encephalomyelitis. Electron microscopic studies.

Authors:  P W Lampert; J K Sims; A J Kniazeff
Journal:  Acta Neuropathol       Date:  1973-03-30       Impact factor: 17.088

10.  Isolation of infectious measles virus in measles encephalitis.

Authors:  V ter Meulen; D Müller; Y Käckell; M Katz; R Meyermann
Journal:  Lancet       Date:  1972-12-02       Impact factor: 79.321

View more
  37 in total

1.  Negative association of Epstein-Barr virus or herpes simplex virus-1 with tumefactive central nervous system inflammatory demyelinating disease.

Authors:  Takao Kiriyama; Hiroshi Kataoka; Takahiko Kasai; Akitaka Nonomura; Satoshi Ueno
Journal:  J Neurovirol       Date:  2010-11-11       Impact factor: 2.643

2.  Ability of herpes simplex virus vectors to boost immune responses to DNA vectors and to protect against challenge by simian immunodeficiency virus.

Authors:  Amitinder Kaur; Hannah B Sanford; Deirdre Garry; Sabine Lang; Sherry A Klumpp; Daisuke Watanabe; Roderick T Bronson; Jeffrey D Lifson; Margherita Rosati; George N Pavlakis; Barbara K Felber; David M Knipe; Ronald C Desrosiers
Journal:  Virology       Date:  2006-09-07       Impact factor: 3.616

3.  Atypical acute hemorrhagic leukoencephalitis (Hurst's disease) presenting with focal hemorrhagic brainstem lesion.

Authors:  Nuhad E Abou Zeid; Joseph D Burns; Eelco F M Wijdicks; Caterina Giannini; B Mark Keegan
Journal:  Neurocrit Care       Date:  2010-02       Impact factor: 3.210

4.  Clinical course, pathological correlations, and outcome of biopsy proved inflammatory demyelinating disease.

Authors:  S J Pittock; R L McClelland; S J Achenbach; F Konig; A Bitsch; W Brück; H Lassmann; J E Parisi; B W Scheithauer; M Rodriguez; B G Weinshenker; C F Lucchinetti
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-12       Impact factor: 10.154

5.  Post-infectious encephalomyelitis: some aetiological mechanisms.

Authors:  P O Behan
Journal:  Postgrad Med J       Date:  1978-11       Impact factor: 2.401

6.  Cranial computed tomography in acute disseminated encephalomyelitis.

Authors:  P Thajeb; S T Chen
Journal:  Neuroradiology       Date:  1989       Impact factor: 2.804

7.  Serial cerebral CT abnormalities in relapsing acute disseminated encephalomyelitis.

Authors:  R W Walker; J Gawler
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-09       Impact factor: 10.154

8.  Acute haemorrhagic leucoencephalitis with a prolonged clinical course.

Authors:  C C Huang; N S Chu; T J Chen; C M Shaw
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-06       Impact factor: 10.154

9.  Pathologic heterogeneity persists in early active multiple sclerosis lesions.

Authors:  Imke Metz; Stephen D Weigand; Bogdan F G Popescu; Josa M Frischer; Joseph E Parisi; Yong Guo; Hans Lassmann; Wolfgang Brück; Claudia F Lucchinetti
Journal:  Ann Neurol       Date:  2014-05-13       Impact factor: 10.422

Review 10.  The pathological spectrum of CNS inflammatory demyelinating diseases.

Authors:  Wei Hu; Claudia F Lucchinetti
Journal:  Semin Immunopathol       Date:  2009-09-25       Impact factor: 9.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.